Enanta Pharmaceuticals (ENTA) EPS (Weighted Average and Diluted) Growth (1y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -82.39% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -97.49% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 61.45% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.15% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,178.57% |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | 57.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.55% |
| Dec 31, 2025 | 60.00% |
| Sep 30, 2025 | 35.29% |
| Jun 30, 2025 | 20.56% |
| Mar 31, 2025 | 27.89% |
| Dec 31, 2024 | 33.54% |
| Sep 30, 2024 | -2.26% |
| Jun 30, 2024 | 42.47% |
| Mar 31, 2024 | 17.88% |
| Dec 31, 2023 | -13.67% |
| Sep 30, 2023 | -4.72% |
| Jun 30, 2023 | -21.57% |
| Mar 31, 2023 | -9.82% |
| Dec 31, 2022 | 6.08% |
| Sep 30, 2022 | -4.10% |
| Jun 30, 2022 | -28.57% |
| Mar 31, 2022 | -49.54% |
| Dec 31, 2021 | -260.98% |
| Sep 30, 2021 | 16.44% |
| Jun 30, 2021 | -67.61% |
| Mar 31, 2021 | -263.33% |
| Dec 31, 2020 | -163.08% |
| Sep 30, 2020 | -431.82% |
| Jun 30, 2020 | -315.15% |
| Mar 31, 2020 | -250.00% |
| Dec 31, 2019 | -48.00% |
| Sep 30, 2019 | -66.15% |
| Jun 30, 2019 | -65.98% |
| Mar 31, 2019 | -67.21% |
| Dec 31, 2018 | 111.86% |
| Sep 30, 2018 | -30.11% |
| Jun 30, 2018 | 320.45% |
| Mar 31, 2018 | 317.86% |
| Dec 31, 2017 | 326.92% |
| Sep 30, 2017 | 2,166.67% |
| Jun 30, 2017 | -633.33% |
| Mar 31, 2017 | -211.11% |
| Dec 31, 2016 | -118.98% |
| Sep 30, 2016 | -131.03% |
| Jun 30, 2016 | -146.15% |
| Mar 31, 2016 | -106.04% |
| Dec 31, 2015 | -37.16% |
| Sep 30, 2015 | 207.41% |
| Jun 30, 2015 | -95.02% |
| Mar 31, 2015 | 632.14% |
| Dec 31, 2014 | 826.67% |
| Sep 30, 2014 | -8.00% |
| Jun 30, 2014 | 1,234.78% |
| Mar 31, 2014 | 87.72% |
| Dec 31, 2013 | -120.69% |
| Sep 30, 2013 | 94.77% |
| Jun 30, 2013 | 94.66% |
| Mar 31, 2013 | -205.07% |